MedPath

Exercise Program on Pain, Physical Function, and Quality of Life in Breast Cancer Survivors

Not Applicable
Active, not recruiting
Conditions
Female Breast Cancer
Interventions
Other: Exercise program
Registration Number
NCT06618690
Lead Sponsor
Universidad de Burgos
Brief Summary

The purpose of this project is to develop a randomized clinical trial to determine the efficacy of a supervised exercise program on pain, physical function and quality of life in female breast cancer survivors

Detailed Description

A randomized, double-blind, clinical trial will be conducted with 325 participants. The intervention group will receive a supervised exercise program for 12 weeks, while the control group will receive no intervention. Participants\' pain, physical function and quality of life will be assessed at baseline, post-intervention and 12 weeks post-intervention.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
325
Inclusion Criteria
  • women between 18 and 65 years of age,
  • women with oncologic treatment completed less than 3 months ago,
  • women without metastasis,
  • women without pathologies that contraindicate exercise,
  • women who have agreed to sign the informed consent form
Exclusion Criteria
  • not attending scheduled sessions to instruct on the exercises to be performed, - being part of other studies,
  • undergoing another type of therapy
  • pregnancy patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Grupo experimentalExercise programThe participants will be recruited through the oncologists of the Hospital Universitario Torrecárdenas (Almería). The proposal will be carried out in the intervention group (group 1), while the control group (group 2) will undergo the conventional recommendations indicated for this type of patients.
Primary Outcome Measures
NameTimeMethod
repeated measures ANOVA12 weeks

the range of motion, tone and muscle strength of the group will be measured in 3 measures over the 12 weeks

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital Universitario Torrecárdenas

🇪🇸

Àlmeria, Alemeria, Spain

© Copyright 2025. All Rights Reserved by MedPath